Forian Inc. (NASDAQ:FORA - Get Free Report)'s share price rose 8.4% on Wednesday . The stock traded as high as $2.67 and last traded at $2.33. Approximately 88,575 shares traded hands during trading, an increase of 350% from the average daily volume of 19,704 shares. The stock had previously closed at $2.15.
Analyst Upgrades and Downgrades
Separately, Roth Mkm reaffirmed a "buy" rating and set a $5.00 price objective on shares of Forian in a report on Thursday, November 14th.
Check Out Our Latest Stock Report on FORA
Forian Stock Performance
The firm has a 50-day moving average price of $2.08 and a 200 day moving average price of $2.21. The stock has a market capitalization of $69.79 million, a P/E ratio of -25.00 and a beta of 1.05.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Forian stock. Elser Financial Planning Inc bought a new position in Forian Inc. (NASDAQ:FORA - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 558,617 shares of the company's stock, valued at approximately $1,151,000. Elser Financial Planning Inc owned about 1.80% of Forian as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 19.25% of the company's stock.
Forian Company Profile
(
Get Free Report)
Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.
Featured Stories
Before you consider Forian, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Forian wasn't on the list.
While Forian currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
